SCHEMBL1246282

SCHEMBL1246282

Cc1cc(OCC=C(c2ccc(C#CCN3CCOCC3)cc2)c2ccc(C#CCN3CCOCC3)cc2)ccc1OC(C)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 5/20 0.49
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42
MMP13 P45452 2/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
FKBP1A P62942 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ACACB O00763 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746387 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1746383 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1746386 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1746477 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1746475 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1746880 0.98 PPARD (0.47) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1747183 0.96 PPARD (0.46) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1747180 0.96 PPARD (0.46) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1747176 0.96 PPARD (0.46) PPARDPPARGPPARAMMP13MMP2
SCHEMBL1744564 0.96 PPARD (0.46) PPARDPPARGPPARAMMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039841-A1 Novel compounds, their preparation and use NOVO NORDISK A/S (DK) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039841-A1 Novel compounds, their preparation and use PPARG, PPARD, PPARA PPARD 2/4885PPARG 1/4885PPARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.